Iliopoulou, V. N., Charkoftaki, G., Cooper, J. C., Dokoumetzidis, A., & Joy, M. S. (2021). Population pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide metabolite in patients with autoimmune glomerulonephritis. Journal of pharmacy and pharmacology, 73(12), 1683. https://doi.org/10.1093/jpp/rgab135
Chicago Style (17th ed.) CitationIliopoulou, Veatriki N., Georgia Charkoftaki, Jennifer C. Cooper, Aristides Dokoumetzidis, and Melanie S. Joy. "Population Pharmacokinetics of Cyclophosphamide and 4-hydroxycyclophosphamide Metabolite in Patients with Autoimmune Glomerulonephritis." Journal of Pharmacy and Pharmacology 73, no. 12 (2021): 1683. https://doi.org/10.1093/jpp/rgab135.
MLA (9th ed.) CitationIliopoulou, Veatriki N., et al. "Population Pharmacokinetics of Cyclophosphamide and 4-hydroxycyclophosphamide Metabolite in Patients with Autoimmune Glomerulonephritis." Journal of Pharmacy and Pharmacology, vol. 73, no. 12, 2021, p. 1683, https://doi.org/10.1093/jpp/rgab135.